The effective management of radiation-induced bowel injury: a randomised controlled trial
ISRCTN | ISRCTN22890916 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN22890916 |
Secondary identifying numbers | N0258191022 |
- Submission date
- 28/09/2007
- Registration date
- 28/09/2007
- Last edited
- 29/03/2022
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Injury, Occupational Diseases, Poisoning
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Contact information
Dr Jervoise Andreyev
Scientific
Scientific
Gastrointestinal Unit, Department of Medicine
Royal Marsden NHS Trust
Fulham Road
London
SW3 6JJ
United Kingdom
Phone | +44 020 7808 2105 |
---|---|
j@andreyev.demon.co.uk |
Study information
Study design | Randomised controlled trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Hospital |
Study type | Quality of life |
Participant information sheet | Not available in web format, please use the contact details to request a patient information sheet |
Scientific title | The effective management of radiation-induced bowel injury: a randomised controlled trial |
Study objectives | To assess which tests can help decide the cause of these patients symptoms' whether treatments in fact improve patients' quality of life and whether these treatments can be delivered usefully by a specialist nurse. |
Ethics approval(s) | The Royal Marsden Research Ethics Committee (now merged with South West London REC1), 26/03/2007, ref: 07/Q0801/47 |
Health condition(s) or problem(s) studied | Injury, Occupational Diseases, Poisoning: Radiation |
Intervention | Randomised test intervention vs standardised intervention, non-blinded (Phase III). Observational (no treatment or diagnostic intervention), Quality of Life Assessment, Qualitative Study |
Intervention type | Other |
Primary outcome measure | Improvement in gastrointestinal symptoms |
Secondary outcome measures | Not provided at time of registration |
Overall study start date | 01/07/2007 |
Completion date | 31/07/2012 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Not Specified |
Sex | Not Specified |
Target number of participants | 250 RMH participants |
Total final enrolment | 218 |
Key inclusion criteria | Patients who have a life expectancy of more than 1 year and who have received radical pelvic radiotherapy with curative intent six months previously and who subsequently have developed new onset troublesome gastrointestinal symptoms |
Key exclusion criteria | Added May 2008: 1. Patient refusing to give informed consent 2. Patients deemed by their clinical oncologist to require immediate gastroenterological assessment |
Date of first enrolment | 26/11/2007 |
Date of final enrolment | 12/12/2011 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
Royal Marsden NHS Trust
London
SW3 6JJ
United Kingdom
SW3 6JJ
United Kingdom
Sponsor information
Record Provided by the NHSTCT Register - 2007 Update - Department of Health
Government
Government
The Department of Health, Richmond House, 79 Whitehall
London
SW1A 2NL
United Kingdom
Phone | +44 (0)20 7307 2622 |
---|---|
dhmail@doh.gsi.org.uk | |
Website | http://www.dh.gov.uk/Home/fs/en |
Funders
Funder type
Government
The Royal Marsden NHS Foundation Trust (UK)
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan | Not provided at time of registration |
Study outputs
Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
---|---|---|---|---|---|
Plain English results | 23/07/2018 | 29/03/2022 | No | Yes |
Editorial Notes
29/03/2022: The following changes have been made:
1. The Cancer Research UK lay results summary has been added.
2. The total final enrolment number has been added.
22/02/2011: The overall trial end date was changed from 30/06/2010 to 31/07/2012.